# Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma

> **NCT03344367** · PHASE1 · UNKNOWN · sponsor: **Peking University** · enrollment: 20 (estimated)

## Conditions studied

- Non Hodgkin Lymphoma

## Interventions

- **BIOLOGICAL:** JWCAR029

## Key facts

- **NCT ID:** NCT03344367
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-16
- **Primary completion:** 2019-10
- **Final completion:** 2022-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2019-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03344367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03344367, "Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03344367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*